BSEAGM/EGM5d ago · 30 Jul 2026, 05:12 pm

Intimation of Book Closure and Cut-off Date for the AGM

Oxygenta Pharmaceutical Ltd · 524636

✦ AI Summary

Oxygenta Pharmaceutical Ltd has announced the book closure and cut-off date for its 33rd Annual General Meeting (AGM) to be held on August 21, 2026. The register of members and share transfer books will be closed from August 15 to 21, 2026, and the company has fixed August 14, 2026, as the cut-off date for remote e-voting.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment1/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Oxygenta Pharmaceutical Ltd - 524636 - Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical Limited.

Attachments (1)

📄

232b00f6-393e-4e80-b11b-f61fb361f815.pdf

pdf

Download →
View document text
VIRUPAKSHA Date: 30.07.2026 The Manager BSE Limited P.J. Towers, Dalal Street Mumbai-400001 Dear Sir/ Madam, Sub: Intimation of Book Closure and Cut-Off Date for the 33™ Annual General Meeting of Oxygenta Pharmaceutical Limited Ref: ISIN: INE102E01018 With reference to the subject cited, this is to inform that the Register of Members and the Share transfer books of the Company will remain closed from 15% August, 2026 to 21* August, 2026 (both days inclusive) for the purpose of 33 Annual General Meeting scheduled to be held on 21% August, 2026 at 10:30 a.m. through Video Conference / Other Audio-Visual Means. Symbol / Stock Type of | Book Closure Record Purpose Scrip Code | Exchange Security Date 524636 BSE Limited | Equity 15T August, 2026 to | - Annual General Shares 21* August, 2026 Meeting (both days inclusive) ‘We would further like to inform that the Company has fixed Friday, 14™ August, 2026 as cut-off date for the purpose of remote e-voting, for ascertaining the names of the Shareholders holding shares either in physical form or in dematerialized form, who will be entitled to cast their votes electronically in respect of the businesses to be transacted at the Annual General Meeting. You are requested to kindly take the same on record for your further needful. Thanking You, Yours faithfully, For Oxygenta Pharmaceutical Limited Balasubba Reddy Mamilla Executive Director (DIN: 01998852) OXYGENTA PHARMACEUTICAL LIMITED (Subsidiary of VIRUPAKSHA ORGANICS LIMITED) (An 1SO 9001:2015, ISO 14001:2018 and ISO 45001:2015 Certified Company) Regd off.& Factory: Sy.No. 252/1, Aroor (V), Sadasivapet (M), Sangareddy (Dist)-502 291, Telangana, INDIA. Tel: 08455-250080 Corp. Office: Level-1, Plot No. B1 & B2, IDA Gandhi Nagar, Kukatpally, Hyderabad — 500 037, Telangana, INDIA. E-Mail id: info@oxygentapharma.com. Website: www.oxygentapharma.com, Phone 040-23073417, CIN: L24110TG1990PLC012038